Inferior prognosis in poor mobilizing myeloma patients
-
Published:2020-06
Issue:3
Volume:59
Page:102722
-
ISSN:1473-0502
-
Container-title:Transfusion and Apheresis Science
-
language:en
-
Short-container-title:Transfusion and Apheresis Science
Author:
Yiğenoğlu Tuğçe NurORCID,
Başcı SemihORCID,
Ulu Bahar UncuORCID,
Bakırtaş MehmetORCID,
Kılınç AliORCID,
Şahin DeryaORCID,
Darçın TahirORCID,
Yıldız JaleORCID,
Baysal Nuran AhuORCID,
İskender DicleORCID,
Çakar Merih KızılORCID,
Dal Mehmet SinanORCID,
Hacıbekiroğlu TubaORCID,
Altuntaş FevziORCID
Reference30 articles.
1. A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Francais du Myelome;Attal;N Engl J Med,1996
2. High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma;Child;N Engl J Med,2003
3. Autologous transplantation and maintenance therapy in multiple myeloma;Palumbo;N Engl J Med,2014
4. Chemotherapy plus lenalidomide versus autologous transplantation, followed by lenalidomide plus prednisone versus lenalidomide maintenance, in patients with multiple myeloma: a randomised, multicentre, phase 3 trial;Gay;Lancet Oncol,2015
5. Lenalidomide, bortezomib, and dexamethasone with transplantation for myeloma;Attal;N Engl J Med,2017
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献